We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+22.14%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.77B
AUM Growth
+$360M
Cap. Flow
+$138M
Cap. Flow %
7.81%
Top 10 Hldgs %
8.01%
Holding
874
New
148
Increased
244
Reduced
232
Closed
198

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$9.45M
2
SNAP icon
Snap
SNAP
+$8.6M
3
NU icon
Nu Holdings
NU
+$7.95M
4
SEDG icon
SolarEdge
SEDG
+$6.9M
5
STLA icon
Stellantis
STLA
+$5.73M

Top Sells

Rank Stock Value
1
SWKS icon
Skyworks Solutions
SWKS
+$8.29M
2
TRGP icon
Targa Resources
TRGP
+$7.01M
3
HUM icon
Humana
HUM
+$6.85M
4
AXSM icon
Axsome Therapeutics
AXSM
+$5.97M
5
ONON icon
On Holding
ONON
+$5.59M

Sector Composition

Rank Sector Weight
1 Technology 22.93%
2 Healthcare 15.99%
3 Consumer Discretionary 15.58%
4 Industrials 12.08%
5 Financials 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVNW icon
626
Aviat Networks
AVNW
$267M
$233K 0.01%
+9,708
New +$196K
NBBK icon
627
NB Bancorp
NBBK
$1B
$229K 0.01%
12,803
-24,483
-66% -$413K
TATT icon
628
TAT Technologies
TATT
$510M
$228K 0.01%
+7,454
New +$214K
MYGN icon
629
Myriad Genetics
MYGN
$276M
$220K 0.01%
41,405
-55,029
-57% -$325K
GSM icon
630
FerroAtlántica
GSM
$592M
$219K 0.01%
59,778
-24,694
-29% -$90.7K
PLTK icon
631
Playtika
PLTK
$1.51B
$217K 0.01%
+45,833
New +$225K
CNH
632
CNH Industrial
CNH
$12.8B
$215K 0.01%
16,560
-9,542
-37% -$118K
CNMD icon
633
CONMED
CNMD
$1.37B
$214K 0.01%
4,101
ETON icon
634
Eton Pharmaceutcials
ETON
$1.27B
$212K 0.01%
14,891
-10,864
-42% -$172K
GLRE icon
635
Greenlight Captial
GLRE
$549M
$209K 0.01%
14,527
-2,219
-13% -$30.5K
FIRY
636
Firy Inc
FIRY
$150M
$206K 0.01%
30,275
DH icon
637
Definitive Healthcare
DH
$72.3M
$205K 0.01%
52,450
BCSF icon
638
Bain Capital Specialty
BCSF
$802M
$204K 0.01%
13,556
-44,018
-76% -$671K
BBT
639
Beacon Financial Corp
BBT
$2.63B
$202K 0.01%
8,071
-12,618
-61% -$314K
HOPE icon
640
Hope Bancorp
HOPE
$1.79B
$197K 0.01%
18,404
-5
-0% -$50
HOFT icon
641
Hooker Furnishings Corp
HOFT
$147M
$190K 0.01%
+17,954
New +$173K
FULC icon
642
Fulcrum Therapeutics
FULC
$240M
$188K 0.01%
+27,280
New +$146K
RLAY icon
643
Relay Therapeutics
RLAY
$4.09B
$186K 0.01%
53,637
PACK icon
644
Ranpak Holdings
PACK
$440M
$184K 0.01%
+51,477
New +$191K
CRGX
645
DELISTED
CARGO Therapeutics
CRGX
$180K 0.01%
43,725
ORLA
646
Orla Mining
ORLA
$3.54B
$176K 0.01%
17,533
-42,807
-71% -$445K
SRI icon
647
Stoneridge
SRI
$192M
$170K 0.01%
24,140
-61,468
-72% -$301K
COGT icon
648
Cogent Biosciences
COGT
$6.75B
$170K 0.01%
23,668
THRD
649
DELISTED
Third Harmonic Bio
THRD
$164K 0.01%
+30,118
New +$150K
BIRD icon
650
Smartbird Inc
BIRD
$19.6M
$163K 0.01%
15,344
+3,545
+30% +$24.8K

Similar funds

PDT Partners's Q2 2025 Portfolio in Review

As of Q2 2025, PDT Partners held 874 positions worth $1.77B, up 26% from $1.41B the previous quarter. Its ten largest holdings account for 8% of the portfolio.

PDT Partners deployed $138M of net new capital in Q2 2025, opening 148 new positions and adding to 244 existing holdings. Its largest new stake was UBS Group: 305,378 shares worth $10.3M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Skyworks Solutions, an estimated $8.29M trimmed.

  • PDT Partners's largest Q2 2025 buy was UBS Group: 305,378 shares worth $10.3M.
  • PDT Partners added most to Snap in Q2 2025, an estimated $8.6M increase.
  • PDT Partners's biggest Q2 2025 reduction was Skyworks Solutions, cutting an estimated $8.29M.
  • PDT Partners fully exited Axsome Therapeutics in Q2 2025, selling an estimated $5.97M.
  • PDT Partners's ten largest holdings make up 8% of its $1.77B portfolio in Q2 2025.
  • PDT Partners opened 148 new positions and closed 198 in Q2 2025.
  • PDT Partners's portfolio value rose 26% quarter-over-quarter to $1.77B.

Based on PDT Partners's 13F filing for Q2 2025, filed 14 Aug 2025.